Generic EpiPen not any cheaper than existing version
A generic competitor to the EpiPen won’t cost any less than the version already on the market, despite the Trump administration touting it as a cheaper alternative. Teva Pharmaceuticals on Tuesday said its drug is now available in limited quantities...
Source: https://ift.tt/2KBZGV7
A generic competitor to the EpiPen won’t cost any less than the version already on the market, despite the Trump administration touting it as a cheaper alternative. Teva Pharmaceuticals on Tuesday said its drug is now available in limited quantities...
Source: https://ift.tt/2KBZGV7
0 Comments